Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

DGEN:US

0.0100 USD 0.0100 50.00%

As of 20:10:00 ET on 05/01/2015.

Snapshot for Deltagen Inc (DGEN)

Open: 0.0100 Day's Range: 0.0100 - 0.0100 Volume: 18,187
Previous Close: 0.0200 52wk Range: 0.0024 - 0.0874 1-Yr Rtn: 0.00%

Stock Chart for DGEN

No chart data available.
  • DGEN:US 0.0100
  • 1D
  • 1M
  • 1Y
0.0200
Interactive DGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DGEN

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -1.5400
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.39
Shares Outstanding (M) 38.85
30 Day Average Volume 10,917
Price/Book (mrq) 0.0284
Price/Sale (ttm) 0.0201
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.0500
Dividend Ex-Date 05/17/2007
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DGEN

No data available

Company Profile & Key Executives for DGEN

Deltagen, Inc. develops technology that converts raw data into mammalian gene function information to help pharmaceutical and biotechnology companies expedite the drug discovery process. The company identifies novel gene targets through the use of advanced bioinformatics.

Constantine E AnagnostopoulosChairmanRobert J DriscollPresident/CEO/Secretary
Daniel RattoChief Financial Officer
More Company Profile & Key Executives for DGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement

Press Releases for DGEN

Advertisement
Sponsored Links
Advertisements
sec ||= nil